Skip to search.
 TSX Down 0.09% TSX Ventures Down 0.48%

More On HBP.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Helix BioPharma Corp (HBP.TO)

-Toronto
2.12 Up 0.10(4.95%) 3:46PM EDT
Add to Portfolio
Prev Close:2.02
Open:2.03
Bid:2.00
Ask:2.12
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.95 - 2.12
52wk Range:1.34 - 2.35
Volume:25,070
Avg Vol (3m):14,500
Market Cap:179.47M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Helix BioPharma Corp., a biopharmaceutical company, develops drugs for the prevention and treatment of cancer based on its proprietary technologies. The company focuses on the development of L-DOS47 that is in phase I/II clinical trial for the tre... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback